KoBioLabs, Inc (KOSDAQ:348150)

KoBioLabs Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,872	5,689	10,047	10,433	52,693	40,627
Short-Term Investments	41,503	50,141	56,194	82,514	33,989	10,348
Trading Asset Securities	-	-	-	-	2,003	-
Cash & Short-Term Investments	49,375	55,830	66,240	92,947	88,685	50,975
Cash Growth	-14.32%	-15.72%	-28.73%	4.81%	73.98%	54.84%
Accounts Receivable	2,081	2,413	1,858	701.91	199.2	2,678
Other Receivables	479.23	917.9	3,020	4,279	3,118	2,475
Receivables	2,560	3,331	4,878	4,991	3,437	5,153
Inventory	5,329	4,468	1,467	977.47	256.21	105.56
Prepaid Expenses	858.77	910.68	1,765	1,852	2,133	1,442
Other Current Assets	1,867	2,143	1,378	1,711	4,108	134.87
Total Current Assets	59,989	66,682	75,729	102,478	98,619	57,810
Property, Plant & Equipment	30,360	31,172	34,858	20,485	5,791	383.21
Long-Term Investments	-0	2,560	2,484	0	0	-0
Other Intangible Assets	713.85	642.24	637.67	279.6	324.2	300.73
Other Long-Term Assets	1,334	1,039	914.62	687.14	541.7	43.32
Total Assets	92,397	102,096	114,623	123,930	105,285	58,537
Accounts Payable	9.54	3.55	-	-	-	-
Accrued Expenses	1,655	1,756	1,127	763.8	543.31	385.63
Short-Term Debt	2,788	3,791	8,633	1,700	-	-
Current Portion of Long-Term Debt	4,026	3,830	58.36	-	1,515	-
Current Portion of Leases	256.37	130.21	234.21	136.51	24.6	28.77
Current Unearned Revenue	300.36	633.16	775.09	120.24	632.53	270.89
Other Current Liabilities	2,594	3,678	10,323	6,223	4,124	2,404
Total Current Liabilities	11,630	13,822	21,151	8,944	6,840	3,089
Long-Term Debt	6,402	8,671	9,172	11,765	7,633	-
Long-Term Leases	224.38	118.06	195.96	180.53	24.37	57.1
Other Long-Term Liabilities	24,031	24,007	22,285	7,586	200	-
Total Liabilities	42,287	46,618	52,804	28,475	14,697	3,146
Common Stock	9,709	9,687	9,436	8,722	8,135	7,759
Additional Paid-In Capital	215,454	215,260	219,114	220,581	208,053	158,760
Retained Earnings	-173,450	-168,125	-162,827	-148,975	-127,053	-111,671
Comprehensive Income & Other	-18,275	-18,997	-21,022	-3,736	577.08	543
Total Common Equity	33,438	37,825	44,702	76,592	89,713	55,391
Minority Interest	16,577	17,558	16,868	18,132	-	-
Shareholders' Equity	50,109	55,477	61,819	95,455	90,589	55,391
Total Liabilities & Equity	92,397	102,096	114,623	123,930	105,285	58,537
Total Debt	13,697	16,540	18,294	13,782	9,197	85.87
Net Cash (Debt)	35,678	39,290	47,946	79,165	79,488	50,889
Net Cash Growth	-13.19%	-18.05%	-39.43%	-0.41%	56.20%	55.09%
Net Cash Per Share	1840.54	2048.20	2587.95	4713.30	4953.80	4747.27
Filing Date Shares Outstanding	19.42	19.37	18.87	17.44	16.27	15.52
Total Common Shares Outstanding	19.42	19.37	18.87	17.44	16.27	15.52
Working Capital	48,359	52,860	54,578	93,535	91,779	54,721
Book Value Per Share	1721.93	1952.37	2368.65	4390.83	5513.80	3569.33
Tangible Book Value	32,724	37,183	44,064	76,312	89,388	55,090
Tangible Book Value Per Share	1685.17	1919.22	2334.86	4374.80	5493.88	3549.95
Land	6,477	6,477	6,477	6,477	-	-
Buildings	14,336	14,308	16,563	5,925	-	-
Machinery	10,936	10,862	4,569	3,920	859.78	634.9
Construction In Progress	-	-	8,766	4,929	5,321	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.